Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Jurnal Mandala Pharmacon Indonesia
Widianti, Audrey Agustin
Unknown Affiliation
Medicine & Pharmacology

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Potential Bioactive Compounds of Mahogany Seeds (Swietenia mahagoni Jacq.) as Antidiabetics through Computational Studies in Silico Molecular Docking Humaedi, Aji; Ardiansyah, Muhamad; Widianti, Audrey Agustin; Sharqoni, Muh Aly
Jurnal Mandala Pharmacon Indonesia Vol. 11 No. 2 (2025): Jurnal Mandala Pharmacon Indonesia 
Publisher : Program Studi Farmasi Universitas Mandala Waluya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35311/jmpi.v11i2.721

Abstract

Diabetes is a chronic endocrine metabolic disorder in insulin production or insulin resistance. Mahogany seeds are plants that have bioactive compounds that can treat diabetes mellitus. This study was conducted to determine the interaction between bioactive compounds of mahogany seeds and the Protein Tyrosine Phosphatase-1B (PTP1B) receptor with PDB ID code: 1T49. Bioactive compounds from mahogany seeds were subjected to docking simulations of 15 compounds with the reference ligand glibenclamide. In silico studies showed an interaction between bioactive compounds of mahogany seeds and PTP1B, the results obtained were in the form of binding energy between the ligand and the target protein. The compound with the best binding energy value was MSC15 (Chisocheton) with a binding energy value of -8.86 kcal/mol. The PyMOL program was used to visualize the 3D conformation of the molecule and ligand-protein interactions, the output was in the form of a Root Mean Square Deviation (RMSD) value of 1,363 Å show good value. The mahogany seed test ligand was also tested pharmacokinetically using the website https://preadmet.bmdrc.kr/  ,Pharmacokinetic parameter tests showed that mahogany seed compounds have excellent intestinal absorption (HIA >90%), strong plasma protein binding (>80%), and variable clearance rates, indicating high potential as an antidiabetic candidate.
Co-Authors Ardiansyah, Muhamad Humaedi, Aji Sharqoni, Muh Aly